Home » Archive by Category


Improving Odds for Women in Tech? Take Notes from Biotech

February 4, 2016 – 6:59 am

At our entrepreneurial support organization, the Council for Entrepreneurial Development (CED), we often joke about adhering to the proper dress and catering code for our networking events: jeans and…

[[Click headline to continue reading.]]

Blood Simple? Grail’s Cancer Screening Quest Faces Tough Questions

February 4, 2016 – 4:30 am

[Corrected, 2/4/16, 2:05pm. See below.] Three weeks ago the world’s biggest genomic sequencing company, Illumina (NASDAQ: ILMN), unveiled a spinout called Grail to make blood tests that could…

[[Click headline to continue reading.]]

ViaCyte Reports on Stem Cell Diabetes Trial, Absorbs BetaLogics

February 3, 2016 – 10:00 pm

[Corrected 2/8/16, 11:20 am. See below.] In a deal that consolidates its position as a leader in developing a stem cell-derived treatment for diabetes, San Diego’s ViaCyte says today it is absorbing…

[[Click headline to continue reading.]]

GenSpera, Pursuing Partners, Tests Toxin-Based Drug in Brain Cancer

February 3, 2016 – 12:57 pm

Like many small biotechs, San Antonio, TX-based GenSpera has plenty of options for developing its cancer drug and limited resources to do so. While GenSpera’s treatment, called mipsagargin or G-202,…

[[Click headline to continue reading.]]

Ex-Tech CEO Steps Out of Retirement to Reinvent Medical Walker

February 3, 2016 – 5:00 am

Dave Purcell meant to stay retired after he ended his 23-year stint with Encad, a San Diego company he co-founded to manufacture large-format inkjet printers capable of printing poster-size images…

[[Click headline to continue reading.]]

Time to Ease On Down the Road

February 3, 2016 – 1:00 am

It’s been a real pleasure writing my guest op-ed pieces for Xconomy for the past six years. I’ve enjoyed sharing my thoughts about a wide spectrum of biopharma topics, and appreciated the feedback I…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Gilead, Adicet, Otonomy, Fate & More

January 29, 2016 – 12:55 am

The only major Republican presidential candidate who didn’t show up for last night’s debate was front-runner Donald Trump. He also made national news this week by announcing his intent to…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: StemCells, Five Prime, Qualcomm & More

January 22, 2016 – 1:30 pm

Bad weather has brought parts of the South and the Eastern seaboard to a halt today, but out west, we’re wearing our gumboots and splashing onward. While the rain drums steadily down, the news…

[[Click headline to continue reading.]]

BioTheranostics, Acquired in 2008, To Go Independent in $32M Deal

January 21, 2016 – 10:01 pm

San Diego-based bioTheranostics, which has operated since 2008 as a division of the French diagnostics conglomerate bioMérieux, said it has secured $32 million in financing to commercialize its…

[[Click headline to continue reading.]]

Love ‘Em? Hate ‘Em? No Matter. The Drug Industry Gets What It Wants.

January 19, 2016 – 4:30 am

Anyone reading this column should be familiar with the fight over drug prices. Many of you would argue that drug makers are too easy a target in political debates and the media, getting little credit…

[[Click headline to continue reading.]]